Company intelligence / Profile preview

Exsurco Medical

Birmingham, Ohio, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

The Amalgatome MD and Amalgatome SD devices by Exsurco Medical are regarded as significant advancements in skin excision, recovery, debridement, and graft harvesting. The technology is widely used in tissue banks and burn/trauma surgery, offering improved speed, precision, and patient safety according to peer-reviewed consensus. Clinical adoption is strong in OPOs (organ procurement organizations), tissue banks, and trauma/burn hospitals, with studies showing high precision, consistent graft thickness, and faster procedures for burn and wound patients.

Therapeutic areas: OtherDermatology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Donate Life America

Beyond the preview

Go deeper on Exsurco Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exsurco Medical.

Explore the full profile